Haemonetics Corporation
HAE
$53.12
-$0.62-1.15%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.32% | 184.68% | 20.02% | 35.82% | -6.50% |
| Total Depreciation and Amortization | -1.30% | 12.97% | 23.35% | 26.19% | 27.28% |
| Total Amortization of Deferred Charges | -- | -22.09% | -- | -- | -- |
| Total Other Non-Cash Items | 163.24% | -405.23% | -33.76% | -20.31% | -332.62% |
| Change in Net Operating Assets | 29.75% | 225.50% | 54.47% | -194.80% | -52.75% |
| Cash from Operations | 163.44% | 81.89% | 8,204.81% | -50.75% | -243.67% |
| Capital Expenditure | 33.63% | -134.00% | -162.29% | 51.42% | 41.47% |
| Sale of Property, Plant, and Equipment | -98.54% | 344.83% | -25.74% | -63.58% | 4,965.17% |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | 2,786.07% | -- | -- | -- |
| Other Investing Activities | -521.70% | -43.18% | 44.06% | -882.50% | 20.80% |
| Cash from Investing | 76.29% | 238.17% | 93.54% | 7.03% | -812.11% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 99.73% | 97.54% | 55.37% | 2,620.00% | -33,486.46% |
| Issuance of Common Stock | -10.54% | 32.08% | 21.32% | -63.73% | 25.84% |
| Repurchase of Common Stock | 50.96% | -- | -944.19% | -1,621.59% | -557.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.84% | 75.00% | -375.93% | -1,764,120.00% | -2,587.95% |
| Cash from Financing | -100.73% | -138.50% | -98.74% | -943.00% | 55,901.34% |
| Foreign Exchange rate Adjustments | 389.41% | 202.55% | -305.63% | 374.46% | 26.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.37% | 7.21% | 113.73% | -169.15% | 13,118.60% |